FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:1179-1189 March 24, 2005 Number 12 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Editorial by Lange, R. A. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background A substantial proportion of patients receiving fibrinolytic therapy for myocardial infarction with ST-segment elevation have inadequate reperfusion or reocclusion of the infarct-related artery, leading to an increased risk of complications and death.

Methods We enrolled 3491 patients, 18 to 75 years of age, who presented within 12 hours after the onset of an ST-elevation myocardial infarction and randomly assigned them to receive clopidogrel (300-mg loading dose, followed by 75 mg once daily) or placebo. Patients received a fibrinolytic agent, aspirin, and when appropriate, heparin (dispensed according to body weight) and were scheduled to undergo angiography 48 to 192 hours after the start of study medication. The primary efficacy end point was a composite of an occluded infarct-related artery (defined by a Thrombolysis in Myocardial Infarction flow grade of 0 or 1) on angiography or death or recurrent myocardial infarction before angiography.

Results The rates of the primary efficacy end point were 21.7 percent in the placebo group and 15.0 percent in the clopidogrel group, representing an absolute reduction of 6.7 percentage points in the rate and a 36 percent reduction in the odds of the end point with clopidogrel therapy (95 percent confidence interval, 24 to 47 percent; P<0.001). By 30 days, clopidogrel therapy reduced the odds of the composite end point of death from cardiovascular causes, recurrent myocardial infarction, or recurrent ischemia leading to the need for urgent revascularization by 20 percent (from 14.1 to 11.6 percent, P=0.03). The rates of major bleeding and intracranial hemorrhage were similar in the two groups.

Conclusions In patients 75 years of age or younger who have myocardial infarction with ST-segment elevation and who receive aspirin and a standard fibrinolytic regimen, the addition of clopidogrel improves the patency rate of the infarct-related artery and reduces ischemic complications.

Source Information

From the TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (M.S.S., C.P.C., C.M.G., C.H.M., E.B.); Hospital Universitario Gregorio Marañon, Madrid (J.L.L.-S.); Institut de Cardiologie, Hôpital Pitié-Salpêtrière, Paris (G.M.); the Montreal Heart Institute, Montreal (P.T.); the Department of Cardiology, University Hospital Antwerp, Edegem, Belgium (M.J.C.); Academisch Ziekenhuis Klina, Brasschaat, Belgium (F.C.); and Nottingham Clinical Research Group, Nottingham, United Kingdom (K.A.H., A.M.S.).

This article was published at www.nejm.org on March 9, 2005.

Address reprint requests to Dr. Sabatine at the TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, 75 Francis St., Boston, MA 02115, or at msabatine{at}partners.org.

Full Text of this Article

Related Letters:

Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction
Chua D., Lo C., Babor E.-M., Sabatine M. S., Cannon C. P., Braunwald E., the CLARITY–TIMI 28 Investigators
Extract | Full Text | PDF  
N Engl J Med 2005; 352:2647-2648, Jun 23, 2005. Correspondence

This article has been cited by other articles:

• Berger, J. S., Bhatt, D. L., Cannon, C. P., Chen, Z., Jiang, L., Jones, J. B., Mehta, S. R., Sabatine, M. S., Steinhubl, S. R., Topol, E. J., Berger, P. B. (2009). The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis.. J Am Coll Cardiol 54: 1935-1945 [Abstract] [Full Text]  
• Harrington, R. A., Stone, G. W., McNulty, S., White, H. D., Lincoff, A. M., Gibson, C. M., Pollack, C. V. Jr., Montalescot, G., Mahaffey, K. W., Kleiman, N. S., Goodman, S. G., Amine, M., Angiolillo, D. J., Becker, R. C., Chew, D. P., French, W. J., Leisch, F., Parikh, K. H., Skerjanec, S., Bhatt, D. L. (2009). Platelet Inhibition with Cangrelor in Patients Undergoing PCI. NEJM 0: NEJMoa0908628v3-1 [Abstract] [Full Text]  
• Bhatt, D. L., Lincoff, A. M., Gibson, C. M., Stone, G. W., McNulty, S., Montalescot, G., Kleiman, N. S., Goodman, S. G., White, H. D., Mahaffey, K. W., Pollack, C. V. Jr., Manoukian, S. V., Widimsky, P., Chew, D. P., Cura, F., Manukov, I., Tousek, F., Jafar, M. Z., Arneja, J., Skerjanec, S., Harrington, R. A., the CHAMPION PLATFORM Investigators, (2009). Intravenous Platelet Blockade with Cangrelor during PCI. NEJM 0: NEJMoa0908629v1-1 [Abstract] [Full Text]  
• RAYMOND, C., MENON, V. (2009). Dual antiplatelet therapy in coronary artery disease: A case-based approach. Cleveland Clinic Journal of Medicine 76: 663-670 [Abstract] [Full Text]  
• Firanescu, C. E., Martens, E. J., Schonberger, J. P.A.M., Soliman Hamad, M. A., van Straten, A. H.M. (2009). Postoperative blood loss in patients undergoing coronary artery bypass surgery after preoperative treatment with clopidogrel. A prospective randomised controlled study. Eur. J. Cardiothorac. Surg. 36: 856-862 [Abstract] [Full Text]  
• Kumar, A., Cannon, C. P. (2009). Acute Coronary Syndromes: Diagnosis and Management, Part II. Mayo Clin Proc. 84: 1021-1036 [Abstract] [Full Text]  
• Dangas, G., Mehran, R., Guagliumi, G., Caixeta, A., Witzenbichler, B., Aoki, J., Peruga, J. Z., Brodie, B. R., Dudek, D., Kornowski, R., Rabbani, L. E., Parise, H., Stone, G. W., for the HORIZONS-AMI Trial Investigators, (2009). Role of Clopidogrel Loading Dose in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty: Results From the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial. J Am Coll Cardiol 54: 1438-1446 [Abstract] [Full Text]  
• Simon, D. I., Parikh, S. A. (2009). Hunting for the "Sweet Spot" in P2Y12 Receptor Blockade. J Am Coll Cardiol 54: 1447-1449 [Full Text]  
• Aranki, S. F., Body, S. C. (2009). Antiplatelet agents used for early intervention in acute coronary syndrome: Myocardial salvage versus bleeding complications.. J. Thorac. Cardiovasc. Surg. 138: 807-810.e7 [Full Text]  
• Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., Mahaffey, K. W., Scirica, B. M., Skene, A., Steg, P. G., Storey, R. F., Harrington, R. A., the PLATO Investigators, (2009). Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes. NEJM 361: 1045-1057 [Abstract] [Full Text]  
• Bohmer, E., Hoffmann, P., Abdelnoor, M., Arnesen, H., Halvorsen, S. (2009). Efficacy and Safety of Immediate Angioplasty Versus Ischemia-Guided Management After Thrombolysis in Acute Myocardial Infarction in Areas With Very Long Transfer Distances: Results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-Elevation Myocardial Infarction). J Am Coll Cardiol 0: j.jacc.2009.08.007v1-15073 [Abstract] [Full Text]  
• Bonaca, M. P., Steg, P. G., Feldman, L. J., Canales, J. F., Ferguson, J. J., Wallentin, L., Califf, R. M., Harrington, R. A., Giugliano, R. P. (2009). Antithrombotics in acute coronary syndromes.. J Am Coll Cardiol 54: 969-984 [Abstract] [Full Text]  
• Moukarbel, G. V., Signorovitch, J. E., Pfeffer, M. A., McMurray, J. J.V., White, H. D., Maggioni, A. P., Velazquez, E. J., Califf, R. M., Scheiman, J. M., Solomon, S. D. (2009). Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial. Eur Heart J 30: 2226-2232 [Abstract] [Full Text]  
• Verstuyft, C., Simon, T., Kim, R. B. (2009). Personalized medicine and antiplatelet therapy: ready for prime time?. Eur Heart J 30: 1943-1963 [Full Text]  
• Ernest, C. S. II, Heathman, M. A., Wrishko, R. E. (2009). Prediction of Prasugrel Active Metabolite Concentrations From 2 Downstream Inactive Metabolite Concentrations Using Multilinear Regression Analysis. J Clin Pharmacol 49: 973-983 [Abstract] [Full Text]  
• Le May, M. R., Wells, G. A., Glover, C. A., So, D. Y., Froeschl, M., Marquis, J.-F., O'Brien, E. R., Turek, M., Thomas, A., Kass, M., Jadhav, S., Labinaz, M. (2009). Primary Percutaneous Coronary Angioplasty With and Without Eptifibatide in ST-Segment Elevation Myocardial Infarction: A Safety and Efficacy Study of Integrilin-Facilitated Versus Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction (ASSIST). Circ Cardiovasc Interv 2: 330-338 [Abstract] [Full Text]  
• Cantor, W. J., Fitchett, D., Borgundvaag, B., Ducas, J., Heffernan, M., Cohen, E. A., Morrison, L. J., Langer, A., Dzavik, V., Mehta, S. R., Lazzam, C., Schwartz, B., Casanova, A., Goodman, S. G., the TRANSFER-AMI Trial Investigators, (2009). Routine Early Angioplasty after Fibrinolysis for Acute Myocardial Infarction. NEJM 360: 2705-2718 [Abstract] [Full Text]  
• APPRAISE Steering Committee and Investigators, (2009). Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome: Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial. Circulation 119: 2877-2885 [Abstract] [Full Text]  
• Van de Werf, F. (2009). Year 2008 ESC ST-segment elevation myocardial infarction guidelines: implications for the interventional cardiologist--from evidence to recommendations and practice. Eur Heart J Suppl 11: C31-C37 [Full Text]  
• Cleanthis, M, Flather, M. (2009). The dangers of stopping clopidogrel perioperatively: a cardiologist's perspective. Clin Risk 15: 106-108 [Full Text]  
• Tousoulis, D., Briasoulis, A., Dhamrait, S. S, Antoniades, C., Stefanadis, C. (2009). Effective platelet inhibition by aspirin and clopidogrel: where are we now?. Heart 95: 850-858 [Full Text]  
• Blasco-Colmenares, E., Perl, T. M., Guallar, E., Baumgartner, W. A., Conte, J. V., Alejo, D., Pastor-Barriuso, R., Sharrett, A. R., Faraday, N. (2009). Aspirin Plus Clopidogrel and Risk of Infection After Coronary Artery Bypass Surgery. Arch Intern Med 169: 788-795 [Abstract] [Full Text]  
• Desai, N. R., Mega, J. L., Jiang, S., Cannon, C. P., Sabatine, M. S. (2009). Interaction between cigarette smoking and clinical benefit of clopidogrel.. J Am Coll Cardiol 53: 1273-1278 [Abstract] [Full Text]  
• Chua, D., Ignaszewski, A. (2009). Clopidogrel in acute coronary syndromes. BMJ 338: b1180-b1180 [Full Text]  
• Jeong, Y. H., Lee, S.-W., Choi, B.-R., Kim, I.-S., Seo, M.-K., Kwak, C. H., Hwang, J.-Y., Park, S.-W. (2009). Randomized Comparison of Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With High Post-Treatment Platelet Reactivity Results of the ACCEL-RESISTANCE (Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With Clopidogrel Resistance) Randomized Study.. J Am Coll Cardiol 53: 1101-1109 [Abstract] [Full Text]  
• Bogaty, P. (2009). Duration of Symptoms Is Not Always the Key Modulator of the Choice of Reperfusion for ST-Elevation Myocardial Infarction. Circulation 119: 1304-1310 [Full Text]  
• Matheny, M. E., Morrow, D. A., Ohno-Machado, L., Cannon, C. P., Sabatine, M. S., Resnic, F. S. (2009). Validation of an Automated Safety Surveillance System with Prospective, Randomized Trial Data. Med Decis Making 29: 247-256 [Abstract]  
• Cohen, M. (2009). Expanding the Recognition and Assessment of Bleeding Events Associated With Antiplatelet Therapy in Primary Care. Mayo Clin Proc. 84: 149-160 [Abstract] [Full Text]  
• Simon, T., Verstuyft, C., Mary-Krause, M., Quteineh, L., Drouet, E., Meneveau, N., Steg, P. G., Ferrieres, J., Danchin, N., Becquemont, L., the French Registry of Acute ST-Elevation and Non-, (2009). Genetic Determinants of Response to Clopidogrel and Cardiovascular Events. NEJM 360: 363-375 [Abstract] [Full Text]  
• Mega, J. L., Close, S. L., Wiviott, S. D., Shen, L., Hockett, R. D., Brandt, J. T., Walker, J. R., Antman, E. M., Macias, W., Braunwald, E., Sabatine, M. S. (2009). Cytochrome P-450 Polymorphisms and Response to Clopidogrel. NEJM 360: 354-362 [Abstract] [Full Text]  
• Terpening, C. (2009). An Appraisal of Dual Antiplatelet Therapy with Clopidogrel and Aspirin for Prevention of Cardiovascular Events. J Am Board Fam Med 22: 51-56 [Abstract] [Full Text]  
• Hamm, C. W., Möllmann, H., Bassand, J.-P., van de Werf, F. (2009). CHAPTER 16 Acute Coronary Syndromes. ESC Textbook of Cardiovascular Medicine 2: med-9780199566990-chapter-med-9780199566990-chapter [Abstract] [Full Text]  
• Authors/Task Force Members, , Van de Werf, F., Bax, J., Betriu, A., Blomstrom-Lundqvist, C., Crea, F., Falk, V., Filippatos, G., Fox, K., Huber, K., Kastrati, A., Rosengren, A., Steg, P. G., Tubaro, M., Verheugt, F., Weidinger, F., Weis, M., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., Document Reviewers, , Silber, S., Aguirre, F. V., Al-Attar, N., Alegria, E., Andreotti, F., Benzer, W., Breithardt, O., Danchin, N., Mario, C. D., Dudek, D., Gulba, D., Halvorsen, S., Kaufmann, P., Kornowski, R., Lip, G. Y. H., Rutten, F. (2008). Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:. Eur Heart J 29: 2909-2945 [Full Text]  
• Dudek, D., Rakowski, T., Dziewierz, A., Kleczynski, P. (2008). PCI after lytic therapy: when and how?. Eur Heart J Suppl 10: J15-J20 [Abstract] [Full Text]  
• Garg, P., Normand, S.-L. T., Silbaugh, T. S., Wolf, R. E., Zelevinsky, K., Lovett, A., Varma, M. R., Zhou, Z., Mauri, L. (2008). Drug-Eluting or Bare-Metal Stenting in Patients With Diabetes Mellitus: Results From the Massachusetts Data Analysis Center Registry. Circulation 118: 2277-2285 [Abstract] [Full Text]  
• Berger, J. S., Frye, C. B., Harshaw, Q., Edwards, F. H., Steinhubl, S. R., Becker, R. C. (2008). Impact of Clopidogrel in Patients With Acute Coronary Syndromes Requiring Coronary Artery Bypass Surgery: A Multicenter Analysis. J Am Coll Cardiol 52: 1693-1701 [Abstract] [Full Text]  
• Goldman, L., Gaspoz, J.-M. (2008). Cost-Effectiveness of Clopidogrel: Seeing through the Smoke. Med Decis Making 28: 803-809 [Abstract]  
• Zimarino, M., De Caterina, R. (2008). Long-term treatment strategies for atherothrombotic disease: do platelets define the course?. Eur Heart J Suppl 10: I8-I13 [Abstract] [Full Text]  
• Husted, S. (2008). Benefits and risks with antiplatelet therapy: how great a problem is bleeding?. Eur Heart J Suppl 10: I19-I24 [Abstract] [Full Text]  
• Vlaar, P. J., Svilaas, T., Damman, K., de Smet, B. J.G.L., Tijssen, J. G.P., Hillege, H. L., Zijlstra, F. (2008). Impact of Pretreatment With Clopidogrel on Initial Patency and Outcome in Patients Treated With Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A Systematic Review. Circulation 118: 1828-1836 [Abstract] [Full Text]  
• Eikelboom, J. W., Hankey, G. J., Thom, J., Bhatt, D. L., Steg, P. G., Montalescot, G., Johnston, S. C., Steinhubl, S. R., Mak, K.-H., Easton, J. D., Hamm, C., Hu, T., Fox, K. A.A., Topol, E. J., on behalf of the Clopidogrel for High Atherothromb, (2008). Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid: Determinants and Effect on Cardiovascular Risk. Circulation 118: 1705-1712 [Abstract] [Full Text]  
• McKellar, S. H., Thompson, J. L. III, Garcia-Rinaldi, R. F., MacDonald, R. J., Sundt, T. M. III, Schaff, H. V. (2008). Short- and long-term efficacy of aspirin and clopidogrel for thromboprophylaxis for mechanical heart valves: an in vivo study in swine.. J. Thorac. Cardiovasc. Surg. 136: 908-914 [Abstract] [Full Text]  
• Mauri, L., Silbaugh, T. S., Garg, P., Wolf, R. E., Zelevinsky, K., Lovett, A., Varma, M. R., Zhou, Z., Normand, S.-L. T. (2008). Drug-Eluting or Bare-Metal Stents for Acute Myocardial Infarction. NEJM 359: 1330-1342 [Abstract] [Full Text]  
• Shishehbor, M. H., Goel, S. S., Kapadia, S. R., Bhatt, D. L., Kelly, P., Raymond, R. E., Galla, J. M., Brener, S. J., Whitlow, P. L., Ellis, S. G. (2008). Long-Term Impact of Drug-Eluting Stents Versus Bare-Metal Stents on All-Cause Mortality. J Am Coll Cardiol 52: 1041-1048 [Abstract] [Full Text]  
• Stone, G. W. (2008). Angioplasty Strategies in ST-Segment-Elevation Myocardial Infarction: Part I: Primary Percutaneous Coronary Intervention. Circulation 118: 538-551 [Full Text]  
• Bates, E. R., Nallamothu, B. K. (2008). Commentary: The Role of Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction. Circulation 118: 567-573 [Full Text]  
• White, H. D. (2008). Systems of Care: Need for Hub-and-Spoke Systems for Both Primary and Systematic Percutaneous Coronary Intervention After Fibrinolysis. Circulation 118: 219-222 [Full Text]  
• Dunning, J., Versteegh, M., Fabbri, A., Pavie, A., Kolh, P., Lockowandt, U., Nashef, S. A.M., on behalf of the EACTS Audit and Guidelines Commit, (2008). Guideline on antiplatelet and anticoagulation management in cardiac surgery.. Eur. J. Cardiothorac. Surg. 34: 73-92 [Abstract] [Full Text]  
• Sullivan, J., Amarshi, N. (2008). Dual antiplatelet therapy with clopidogrel and aspirin. Am J Health Syst Pharm 65: 1134-1143 [Abstract] [Full Text]  
• Schiele, F., Meneveau, N., Bassand, J.-P. (2008). Routine pre-treatment with clopidogrel before diagnostic coronary angiography: the question is right, but what about the answer?. Eur Heart J 29: 1475-1477 [Full Text]  
• Natarajan, A., Zaman, A. G, Marshall, S. M (2008). Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents. Diabetes and Vascular Disease Research 5: 138-144 [Abstract]  
• Weintraub, W. S. (2008). Pharmacoeconomic Concepts in Antiplatelet Therapy: Understanding Cost-Effectiveness Analyses Using Clopidogrel as an Example. J CARDIOVASC PHARMACOL THER 13: 107-119 [Abstract]  
• Patrono, C., Baigent, C., Hirsh, J., Roth, G. (2008). Antiplatelet Drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 199S-233S [Abstract] [Full Text]  
• Goodman, S. G., Menon, V., Cannon, C. P., Steg, G., Ohman, E. M., Harrington, R. A. (2008). Acute ST-Segment Elevation Myocardial Infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 708S-775S [Abstract] [Full Text]  
• Becker, R. C., Meade, T. W., Berger, P. B., Ezekowitz, M., O'Connor, C. M., Vorchheimer, D. A., Guyatt, G. H., Mark, D. B., Harrington, R. A. (2008). The Primary and Secondary Prevention of Coronary Artery Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 776S-814S [Abstract] [Full Text]  
• Toyoda, K., Yasaka, M., Iwade, K., Nagata, K., Koretsune, Y., Sakamoto, T., Uchiyama, S., Gotoh, J., Nagao, T., Yamamoto, M., Takahashi, J. C., Minematsu, K., for the Bleeding with Antithrombotic Therapy (BAT), (2008). Dual Antithrombotic Therapy Increases Severe Bleeding Events in Patients With Stroke and Cardiovascular Disease: A Prospective, Multicenter, Observational Study. Stroke 39: 1740-1745 [Abstract] [Full Text]  
• Morrow, D. A. (2008). Antithrombotic Therapy to Support Primary PCI. NEJM 358: 2280-2282 [Full Text]  
• Cairns, J. A., Eikelboom, J. (2008). Clopidogrel Resistance: More Grist for the Mill. J Am Coll Cardiol 51: 1935-1937 [Full Text]  
• Busk, M., Maeng, M., Rasmussen, K., Kelbaek, H., Thayssen, P., Abildgaard, U., Vigholt, E., Mortensen, L. S., Thuesen, L., Kristensen, S. D., Nielsen, T. T., Andersen, H. R., for the DANAMI-2 Investigators, (2008). The Danish multicentre randomized study of fibrinolytic therapy vs. primary angioplasty in acute myocardial infarction (the DANAMI-2 trial): outcome after 3 years follow-up. Eur Heart J 29: 1259-1266 [Abstract] [Full Text]  
• Bassand, J.-P. (2008). Unmet needs in antiplatelet therapy. Eur Heart J Suppl 10: D3-D11 [Abstract] [Full Text]  
• Sabatine, M. S., Morrow, D. A., Higgins, L. J., MacGillivray, C., Guo, W., Bode, C., Rifai, N., Cannon, C. P., Gerszten, R. E., Lee, R. T. (2008). Complementary Roles for Biomarkers of Biomechanical Strain ST2 and N-Terminal Prohormone B-Type Natriuretic Peptide in Patients With ST-Elevation Myocardial Infarction. Circulation 117: 1936-1944 [Abstract] [Full Text]  
• Kapoor, J. R., Patrono, C., Davi, G. (2008). Platelet Activation and Atherothrombosis. NEJM 358: 1638-1639 [Full Text]  
• O'Donoghue, M., Morrow, D. A., Cannon, C. P., Guo, W., Murphy, S. A., Gibson, C. M., Sabatine, M. S. (2008). Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapy. Eur Heart J 29: 984-991 [Abstract] [Full Text]  
• BAKHRU, M. R., BHATT, D. L. (2008). INTERPRETING THE CHARISMA STUDY: What is the role of dual antiplatelet therapy with clopidogrel and aspirin?. Cleveland Clinic Journal of Medicine 75: 289-295 [Abstract] [Full Text]  
• Henriksen, P. A., Palmer, K., Boon, N. A. (2008). Management of upper gastrointestinal haemorrhage complicating dual anti-platelet therapy. QJM 101: 261-267 [Abstract] [Full Text]  
• Reaume, K. T, Regal, R. E, Dorsch, M. P (2008). Indications for Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Evidence-Based Recommendations for Use. The Annals of Pharmacotherapy 42: 550-557 [Abstract] [Full Text]  
• Michelson, A. D. (2008). P2Y12 Antagonism: Promises and Challenges. Arterioscler. Thromb. Vasc. Bio. 28: s33-s38 [Abstract] [Full Text]  
• Gibson, C. M., Pride, Y. B., Buros, J. L., Lord, E., Shui, A., Murphy, S. A., Pinto, D. S., Zimetbaum, P. J., Sabatine, M. S., Cannon, C. P., Josephson, M. E., for the TIMI Study Group, (2008). Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.. J Am Coll Cardiol 51: 546-551 [Abstract] [Full Text]  
• Li, J. S., Yow, E., Berezny, K. Y., Bokesch, P. M., Takahashi, M., Graham, T. P. Jr, Sanders, S. P., Sidi, D., Bonnet, D., Ewert, P., Jennings, L. K., Michelson, A. D., for the PICOLO Investigators, (2008). Dosing of Clopidogrel for Platelet Inhibition in Infants and Young Children: Primary Results of the Platelet Inhibition in Children On cLOpidogrel (PICOLO) Trial. Circulation 117: 553-559 [Abstract] [Full Text]  
• American College of Cardiology/American Heart Asso, , Developed in Collaboration With the Canadian Cardi, , Endorsed by the American Academy of Family Physici, , 2007 Writing Group to Review New Evidence and Upda, , Antman, E. M., Hand, M., Armstrong, P. W., Bates, E. R., Green, L. A., Halasyamani, L. K., Hochman, J. S., Krumholz, H. M., Lamas, G. A., Mullany, C. J., Pearle, D. L., Sloan, M. A., Smith, S. C. JR (2008). 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction. J Am Coll Cardiol 51: 210-247 [Full Text]  
• American College of Cardiology/American Heart Asso, , 2007 Writing Group to Review New Evidence and Upda, , King, S. B. III, Smith, S. C. Jr, Hirshfeld, J. W. Jr, Jacobs, A. K., Morrison, D. A., Williams, D. O. (2008). 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention. J Am Coll Cardiol 51: 172-209 [Full Text]  
• Antman, E. M., Hand, M., Armstrong, P. W., Bates, E. R., Green, L. A., Halasyamani, L. K., Hochman, J. S., Krumholz, H. M., Lamas, G. A., Mullany, C. J., Pearle, D. L., Sloan, M. A., Smith, S. C. Jr, 2004 Writing Committee Members, , Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., Lamas, G. A., Mullany, C. J., Ornato, J. P., Pearle, D. L., Sloan, M. A., Smith, S. C. Jr, Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Buller, C. E., Creager, M. A., Ettinger, S. M., Halperin, J. L., Hunt, S. A., Krumholz, H. M., Kushner, F. G., Lytle, B. W., Nishimura, R., Page, R. L., Riegel, B., Tarkington, L. G., Yancy, C. W. (2008). 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the Canadian Cardiovascular Society Endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation 117: 296-329 [Full Text]  
• King, S. B. III, Smith, S. C. Jr, Hirshfeld, J. W. Jr, Jacobs, A. K., Morrison, D. A., Williams, D. O., 2005 WRITING COMMITTEE MEMBERS, , Smith, S. C. Jr, Feldman, T. E., Hirshfeld, J. W. Jr, Jacobs, A. K., Kern, M. J., King, S. B. III, Morrison, D. A., O'Neill, W. W., Schaff, H. V., Whitlow, P. L., Williams, D. O., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Buller, C. E., Creager, M. A., Ettinger, S. M., Halperin, J. L., Hunt, S. A., Krumholz, H. M., Kushner, F. G., Lytle, B. W., Nishimura, R., Page, R. L., Riegel, B., Tarkington, L. G., Yancy, C. W. (2008). 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation 117: 261-295 [Full Text]  
• Gitt, A. K., Betriu, A. (2008). Antiplatelet therapy in acute coronary syndromes. Eur Heart J Suppl 10: A4-A12 [Abstract] [Full Text]  
• Bode, C., Huber, K. (2008). Antiplatelet therapy in percutaneous coronary intervention. Eur Heart J Suppl 10: A13-A20 [Abstract] [Full Text]  
• Bertrand, M. E. (2008). When and how to discontinue antiplatelet therapy. Eur Heart J Suppl 10: A35-A41 [Abstract] [Full Text]  
• Jones, J B, Docherty, A (2007). Non-invasive treatment of ST elevation myocardial infarction. Postgrad. Med. J. 83: 725-730 [Abstract] [Full Text]  
• Bhatt, D. L. (2007). Intensifying Platelet Inhibition -- Navigating between Scylla and Charybdis. NEJM 357: 2078-2081 [Full Text]  
• Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., Riesmeyer, J., Weerakkody, G., Gibson, C. M., Antman, E. M., the TRITON-TIMI 38 Investigators, (2007). Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes. NEJM 357: 2001-2015 [Abstract] [Full Text]